Prolonging Survival in Advanced Esophageal Squamous Cell Carcinoma With Immune Checkpoint Inhibitors

Posted on June 2, 2022 by Gastroenterology Journal

Doki Y, Ajani A, Xu L, et al. Nivolumab combination therapy in advanced esophageal squamous-cell carcinoma. N Engl J Med 2022;386:449–462.

This entry was posted in News. Bookmark the permalink.